youtube_live
Q3 2026 earnings тАв released тАв EPS beat +резрез.рейрео% тАв Revenue beat +рен.рейрей%
See resultschevron_right
AGIO:NASDAQ
Agios Pharmaceuticals Inc
US$┬ареиреп.рекрез
arrow_upward
+рек.режрей%(+рез.резрек) 1D
US$┬ареирео.репрен
arrow_downward
-рез.релреж% (-реж.рекрек)bedtimeAfter hours
Closed: рдиреЛрднреЗрдореНрдмрд░ рем, резрем:режреж:режрез GMT-рел · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for AGIO...
Open
US$┬ареирео.репреп
High
US$┬ареиреп.реореж
Low
US$┬ареирео.рекрем
Mkt. cap
рез.ренрем┬ардЕрд░рдм
Avg. vol.
резреи.реорек┬ард▓рд╛рдЦ
Volume
резреи.реорез┬ард▓рд╛рдЦ
52-wk high
US$┬арекрел.репреп
52-wk low
US$┬ареиреи.реирек
EPS
-US$┬арен.режрез
Beta
реж.ремрем
Shares outstanding
рел.репрен┬ардХрд░реЛрдб
No. of employees
релрекреж
Open
US$┬ареирео.репреп
High
US$┬ареиреп.реореж
Low
US$┬ареирео.рекрем
Mkt. cap
рез.ренрем┬ардЕрд░рдм
Avg. vol.
резреи.реорек┬ард▓рд╛рдЦ
Volume
резреи.реорез┬ард▓рд╛рдЦ
52-wk high
US$┬арекрел.репреп
52-wk low
US$┬ареиреи.реирек
EPS
-US$┬арен.режрез
Beta
реж.ремрем
Shares outstanding
рел.репрен┬ардХрд░реЛрдб
No. of employees
релрекреж
Related stocks
News stories
From web sources and news partners
TradingView
·
рей рджрд┐рди рдкрд╣рд┐рд▓реЗ
What Agios Pharmaceuticals (AGIO) Said on Its Q3 Earnings Call
Benzinga
·
рей рджрд┐рди рдкрд╣рд┐рд▓реЗ
Agios Pharmaceuticals Q3 2026 Earnings Call Transcript
GuruFocus
·
рей рджрд┐рди рдкрд╣рд┐рд▓реЗ
Agios Pharmaceuticals Reports Q3 2026 Revenue of $55.4 Million,
Investing.com Nigeria
·
рей рджрд┐рди рдкрд╣рд┐рд▓реЗ
Agios earnings beat by $0.15, revenue topped estimates
Profile
Agios Pharmaceuticals Inc. is a publicly trading American pharmaceutical company pioneering therapies for genetically defined diseases, with a near-term focus on developing therapies for hemolytic anemias. The company was founded in 2008 by Lewis Cantley, Tak Mak and Craig Thompson. Agios is a Delaware corporation headquartered in Cambridge, Massachusetts. The company tendered an initial public offering in July 2013. Wikipedia
About Agios Pharmaceuticals Inc